Showing results (41-50 of 76) with videos related to
Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1988
Thromboxane synthesis and actions in isolated adrenergic nerve (pheochromocytoma-12) cellsG J Trachte, P J Hook, J R Kemp, et al.Pharmacotherapy|August 12, 2000
Semen and serum pharmacokinetics of zidovudine and zidovudine-glucuronide in men with HIV-1 infectionP L Anderson, S E Noormohamed, K Henry, et al.AIDS (London, England)|November 23, 2000
Indinavir plasma protein binding in HIV-1-infected adultsP L Anderson, R C Brundage, L Bushman, et al.Antimicrobial Agents and Chemotherapy|July 1, 1997
Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDSC V Fletcher, B K Goodroad, L M Cummins, et al.Cytokine|November 6, 2007
Cloning and characterization of recombinant rhesus macaque IL-10/Fc(ala-ala) fusion protein: a potential adjunct for tolerance induction strategiesC Asiedu, V Guarcello, L Deckard, et al.JAMA|May 27, 1988
Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complexK Henry, B J Chinnock, R P Quinn, et al.Antimicrobial Agents and Chemotherapy|May 11, 1991
Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipientsC V Fletcher, J A Englund, C K Edelman, et al.Antimicrobial Agents and Chemotherapy|December 1, 1988
Ganciclovir pharmacokinetics during renal impairmentK D Lake, C V Fletcher, K R Love, et al.Cancer Chemotherapy and Pharmacology|October 6, 2000
Phase I dose escalation pharmacokinetics of O-(chloroacetylcarbamoyl) fumagillol (TNP-470) and its metabolites in AIDS patients with Kaposi's sarcomaJ D Moore, B J Dezube, P Gill, et al.Clinical Pharmacology and Therapeutics|July 5, 2007
Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trialC V Fletcher, R C Brundage, T Fenton, et al.Pageof 8